Displaying all 3 drugs
Hydroxyurea
Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized biologically until 1928. It was first approved by the FDA in 1998 for the treatment of sickle cell anemia in adults. Although clinical evidence on the efficacy of hydroxyurea in certain conditions exists, hydroxyurea...
Approved
Matched International brands: … Onco-Carbide …
Matched Products: … ONCO CARBIDE …
Matched Products: … ONCO CARBIDE …
Tantalum
Tantalum has been investigated for the treatment and prevention of Osteoarthritis, Knee Osteoarthritis, Intraoperative Bleeding, and Adolescent Idiopathic Scoliosis.
Investigational
Matched Name: … Tantalum …
Matched Iupac: … tantalum …
Matched Description: … Tantalum has been investigated for the treatment and prevention of Osteoarthritis, Knee Osteoarthritis …
Matched Iupac: … tantalum …
Matched Description: … Tantalum has been investigated for the treatment and prevention of Osteoarthritis, Knee Osteoarthritis …
Hexatantalum Dodecabromide
Experimental
Matched Iupac: … tantalum(1+) undecahydrobromide pentatantalum bromide …
Displaying all 3 drugs